Table 2.
Advisory Committee | New Devices | Percent |
---|---|---|
Circulatory System | 241 | 28.45 |
Opthalmic | 160 | 18.89 |
Microbiology | 74 | 8.74 |
General and Plastic Surgery | 60 | 7.08 |
Gastroenterology-Urology | 53 | 6.26 |
Orthopedic and Rehabilitation | 53 | 6.26 |
Immunology | 38 | 4.49 |
Obstetrics and Gynecology | 33 | 3.90 |
Radiology | 28 | 3.31 |
General Hospital and Personal use | 23 | 2.72 |
Clinical Chemistry and Toxicology | 17 | 2.01 |
Dental | 15 | 1.77 |
Ear, nose and throat | 13 | 1.53 |
Neurology | 13 | 1.53 |
Anesthesiology | 12 | 1.42 |
Physical Medicine | 8 | 0.94 |
Hematology and pathology | 6 | 0.71 |
| ||
(Total) | 847 | 100.00 |
This table shows the distribution of all 847 new devices analyzed in this study by FDA (specialty-specific) Advisory Committee.